STAB OTC
Statera Biopharma, Inc.
1W: -99.0%
1M: -99.5%
3M: -99.0%
YTD: -99.7%
1Y: -99.0%
3Y: -99.9%
$0.00
+0.00 (+0.00%)
Weekly Expected Move ±54.3%
$-0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$488K
+0.0% ▲
Operating Income
-$98M
-836.5% ▼
Net Income
-$174M
-1218.8% ▼
EPS (Diluted)
$-4.97
-855.8% ▼
EBITDA
-$171M
+477.0% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $0 | $0 | $488K |
| Gross Profit | $0 | $0 | $0 | $0 | -$488K |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $5M | $4M | $587K | $5M | $12M |
| SG&A Expenses | $3M | $2M | $2M | $5M | $18M |
| Operating Expenses | $8M | $6M | $3M | $11M | $29M |
| Operating Income | -$6M | -$5M | -$3M | -$11M | -$98M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $0 | $0 | $124K | $1M | $0 |
| Income Before Tax | -$10M | -$4M | -$3M | -$12M | -$102M |
| Tax Expense | -$53K | $0 | $124K | $1M | $73M |
| Net Income | -$10M | -$4M | -$3M | -$13M | -$174M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-0.87 | $-0.32 | $-0.13 | $-0.52 | $-4.97 |
| EBITDA | -$6M | -$5M | -$3M | -$11M | -$171M |
| Shares Outstanding | 11M | 11M | 26M | 26M | 35M |